With Inside U Miami Medicine, we explore our academic medicine ecosystem. We chat with researchers making groundbreaking discoveries, changemakers toppling barriers, and physicians reimagining the future of health care. We tackle tough topics and delve into complex challenges. Join us for transformative conversations hosted by Henri R. Ford, M.D., M.H.A., dean and chief academic officer of the University of Miami Miller School of Medicine.
Firefighters sprint into dangerous situations to protect their communities. But what happens when the very act of helping others puts their own lives at risk?
Dr. Erin Kobetz and Dr. Alberto Caban-Martinez - leaders of the Firefighter Cancer Initiative at Sylvester Comprehensive Cancer Center - pull back the curtain on a health crisis: the elevated cancer risk firefighters face because of toxic exposures on the job.
Neurologist Dr. Ihtsham ul Haq reveals how cutting-edge technology is reshaping diagnosis and why stem cell therapies may hold the power to slow, or even reverse, the disease. Discover the breakthroughs, the setbacks and the race to change the future of Parkinson’s.
Autoimmune diseases like lupus and Type 1 diabetes are notoriously difficult to treat, but what if we could reprogram the immune system instead of turning it off entirely?
Preeminent immunologist Dr. Thomas Malek dives into the science behind a lab-designed fusion protein that could offer a powerful new path to long-term remission.
In this critical moment for academic medicine and scientific discovery, how can we rebuild trust in our institutions and our work? Dr. Elena Fuentes-Afflick, chief scientific officer of the Association of American Medical Colleges (AAMC) and a leading voice in support of research, joined us to tackle challenging questions and provide insight for scientists at all stages of their academic career.
Humans share 99% of their genes but, according to JacobMcCauley, Ph.D., “that one percent can tell us a lot.” The “1%” in genetic studies refers to the miniscule fraction of DNA that differentiates any two individuals but may be the key for understanding disease susceptibility.
This small variation is leading to significant discoveries.
Step into the mind of one of neurosurgery’s most influentialvoices: Michael Wang, M.D., M.B.A., a globally recognized spine surgeon and leader of the largest spine fellowship program in the country.
Dr. Wang and Dean Henri Ford tackle some of the most pressing challenges for spine surgeons: society scrutiny, public perception, patient trust, work-life balance, spiritual weight of the job and more. And for future and current doctors...
Microplastics and their synthetic byproducts pose a majorrisk to humans through inhalation and ingestion. Could these microscopic pollutants play a role in infertility or cancer? Dr. Raveen Syan and her team are determined to find out.
Dr. Raveen Syan, assistant professor of clinical urology at the Desai Sethi Urology Institute, and Christina Yarborough, a medical student, joined the podcast to discuss a groundbreaking study that wi...
Atrial fibrillation leads to stroke, heart failure, sudden death and other health problems for millions worldwide. Yet, despite decades of research, many aspects of AFib care — from diagnosis to treatment — remain outdated.
Dr. Jeffrey Goldberger joined Inside U Miami Medicine to share how he is improving decades-old models to save lives.
“I saw two patients in the office within one month of each other. They had no risk factors. They...
Prostate cancer affects more than half of males by age 80. Yet, early intervention can lead to complications that profoundly reduce quality of life. In the latest episode of “Inside U Miami Medicine,” luminaries in the field of urology mull over the complex question: Does every prostate cancer diagnosis require immediate treatment?
Dr. Ian Thompson, professor emeritus at the University of Texas Health Science Center San Antonio, h...
The field of radiology is in flux, shifting with wave after wave of advanced technology. While the public speculated whether artificial intelligence (AI) might render radiologists obsolete, the experts were already harnessing its power to optimize workflows, alleviate burnout, improve patient care, and redefine their role within the health care team.
At the forefront of this transformation is Dr. Alexander McKinney, Shapiro profes...
The world of migraine is complex and often misunderstood, even though it’s one the most disabling neurologic disorders in the world. Despite its prevalence, this common disease remains deeply stigmatized.
Teshamae Monteith, M.D., a nationally recognized headache expert, sheds light on groundbreaking research, pharmaceutical innovations and emerging treatments that aim to reshape the way we think about and treat migraine.
Prostate cancer is the 2nd most common cause of cancer death in U.S. men. While initial treatments offer hope, many patients find that their cancer returns with often fatal outcomes. But what if the key to stopping this deadly progression lies in our genes?
Dr. Nima Sharifi, scientific director of the Desai Sethi Urology Institute, discovered a specific genetic variant that enables tumors to bypass treatments, effectively producing...
Dr. David Davis, is breaking new ground in understanding how toxins, especially microplastics, may contribute to neurodegenerative diseases like Alzheimer's, ALS, and Parkinson's.
In this episode of Inside U Miami Medicine, Dr. Davis shares his journey and the groundbreaking methodologies he developed to detect and study these toxins. From cyanobacterial blooms to airborne plastic particles, he reveals the urgent need to a...
We’re exploring visionary breakthroughs in the field of ophthalmology with Eduardo Alfonso, M.D., director of Bascom Palmer Eye Institute. Dr. Alfonso has his sight set on an ambitious project - whole eye transplant. He and his team are currently exploring the use of an ECMO device to preserve a donated eye, enabling them to apply gene therapy and stem cells, replace specific parts of the organ, and enhance its functionality.
Tune...
Dr. Helen Bermudez, a gastroenterology fellow, overcame immense challenges to pursue her dream. Born in Cuba, she immigrated to the U.S. at age 15. She spoke no English but carried an unwavering dedication to help others through medicine. Tune in as we explore Dr. Bermudez’s story of resilience and the advice she offers others facing similar paths.
Dr. Ashish Shah, a neurosurgeon and brain cancer researcher at Sylvester Comprehensive Cancer Center, is weaponizing viruses to make brain cancer cells more susceptible to chemotherapy and radiation. It’s a delicate process that involves delivering viral-based gene therapy directly into the tumor or tumor cavity to alter the fundamental genome of the cancer cells.
Tune in to learn how this treatment is offering new hope for gliobla...
When the very treatment keeping a patient alive also exacts a heavy toll on lives, researchers are compelled to ask, “Is there another way?”
Glioblastoma is a brutal brain cancer. It is aggressive, common and nearly always fatal. Standard treatments of radiation and chemotherapy often leave patients with cognitive problems and a diminished quality of life.
But Dr. Macarena de la Fuente, chief of the Neuro oncology Division at Sylv...
In the vast landscape of medical research, few areas are as intricate and nuanced as traumatic brain injury. However, amidst these profound challenges lies the relentless pursuit of understanding and innovation spearheaded by pioneers like Dr. Dalton Dietrich.
Dr. Dietrich, scientific director of the Miami Project to Cure Paralysis, recently joined the Inside U Miami Medicine podcast to share the latest neuroscience discoveries an...
When disaster occurs, Dr. Elizabeth Greig runs toward the chaos. She and her team follow in the wake of hurricanes, earthquakes and other hazardous events to help the world’s most vulnerable communities heal and rebuild. They provide medical care and essential resources, bolster infrastructure and strengthen the health sector. Sometimes, they construct buildings. As of April 2024, a hospital they helped erect in Port-au-Prince, Hai...
Raymond Schinazi, Ph.D., a world-renowned scientist, knows that research requires resilience. “I have file cabinets full of rejections,” he said.
In the second part of our episode with Dr. Schinazi, we explore how he developed a life-saving cure for Hepatitis C, despite being denied funding from the NIH. Instead of giving up and focusing on other antivirals, he founded his own biotech company and set his sights on revolutionizing t...
The latest news in 4 minutes updated every hour, every day.
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Charlie is America's hardest working grassroots activist who has your inside scoop on the biggest news of the day and what's really going on behind the headlines. The founder of Turning Point USA and one of social media's most engaged personalities, Charlie is on the front lines of America’s culture war, mobilizing hundreds of thousands of students on over 3,500 college and high school campuses across the country, bringing you your daily dose of clarity in a sea of chaos all from his signature no-holds-barred, unapologetically conservative, freedom-loving point of view. You can also watch Charlie Kirk on Salem News Channel